Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 26, 2022; 10(24): 8547-8555
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8547
Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis
Dong Liu, Jian-Ming Fang, Xian-Qi Chen
Dong Liu, Department of General Surgery, Yongkang First People’s Hospital of Zhejiang Province, Yongkang 321300, Zhejiang Province, China
Jian-Ming Fang, Xian-Qi Chen, Department of Hepatopancreatobiliary Surgery, Jinhua Guangfu Oncology Hospital, Jinhua 321000, Zhejiang Province, China
Author contributions: Liu D and Chen XQ designed the research study; Liu D performed the research; Fang JM contributed new reagents and analytic tools; Liu D analyzed the data and wrote the manuscript; and all authors have read and approve the final manuscript.
Supported by Key Scientific Research Project of Jinhua Science and Technology Bureau in 2020 Fund, No. 2020-3-069.
Institutional review board statement: The study was reviewed and approved by the Yongkang First People’s Hospital of Zhejiang Province Institutional Review Board.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: Dr. Chen XQ reports grants from Scientific Research Project of Jinhua Science and Technology Bureau in 2020, during the conduct of the study. No other conflict of interest to declare.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xian-Qi Chen, BM BCh, Attending Doctor, Department of Hepatopancreatobiliary Surgery, Jinhua Guangfu Oncology Hospital, No. 1296 Huancheng North Road, Jinhua 321000, Zhejiang Province, China. cxqclz1988@163.com
Received: April 19, 2022
Peer-review started: April 19, 2022
First decision: May 11, 2022
Revised: May 23, 2022
Accepted: July 20, 2022
Article in press: July 20, 2022
Published online: August 26, 2022
Core Tip

Core Tip: There are differences in the selection of different blood-flow blocking techniques during hepatocellular carcinoma (HCC) surgery. We explore surgical effect of half hepatic blood flow occlusion and liver function recovery of patients with hepatocirrhosis HCC in hepatectomy.